T2 Biosystems, Inc.·4

Apr 6, 1:08 PM ET

Gibbs Michael Terrence 4

4 · T2 Biosystems, Inc. · Filed Apr 6, 2023

Insider Transaction Report

Form 4
Period: 2023-03-28
Gibbs Michael Terrence
General Counsel
Transactions
  • Sale

    Common Stock

    2023-03-28$0.48/sh239$1156,612 total
Footnotes (1)
  • [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2018.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4